BlackRock, Inc. 13D and 13G filings for Bio-Rad Laboratories, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-08 5:31 pm Unchanged | 2024-09-30 | 13G | Bio-Rad Laboratories, Inc. BIO | BlackRock Inc. BLK | 1,929,864 8.500% | 0 (Unchanged) | Filing |
| 2024-10-22 3:24 pm Purchase | 2024-09-30 | 13G | Bio-Rad Laboratories, Inc. BIO | BlackRock Inc. BLK | 1,929,864 8.500% | 463,638 (+31.62%) | Filing |
| 2024-01-29 5:25 pm Sale | 2023-12-31 | 13G | Bio-Rad Laboratories, Inc. BIO | BlackRock Inc. BLK | 1,466,226 6.100% | -116,087 (-7.34%) | Filing |
| 2023-01-31 5:52 pm Sale | 2022-12-31 | 13G | Bio-Rad Laboratories, Inc. BIO | BlackRock Inc. BLK | 1,582,313 6.400% | -185,768 (-10.51%) | Filing |
| 2022-01-31 5:49 pm Sale | 2021-12-31 | 13G | Bio-Rad Laboratories, Inc. BIO | BlackRock Inc. BLK | 1,768,081 7.100% | -124,255 (-6.57%) | Filing |
| 2021-01-28 5:56 pm Sale | 2020-12-31 | 13G | Bio-Rad Laboratories, Inc. BIO | BlackRock Inc. BLK | 1,892,336 7.600% | -426,716 (-18.40%) | Filing |